Author: OurCrowd

[Foretellix in PR Newswire] Foretellix tackles largest barriers to safe autonomy

TEL AVIV, Israel, Jan. 3, 2023 /PRNewswire/ — Foretellix, the leading provider of verification and validation solutions, unveils today a new Safety-Driven Verification and Validation paradigm for large-scale deployment of Automated Driving Systems. The new holistic approach addresses an industry mandate to bridge a growing gap between traditional manual safety engineering processes and automated scenario-based verification and validation that hinders the commercial deployment of Automated Driving Systems. Read...

Read More

[InsideTracker in PR Newswire] InsideTracker adds Apolipoprotein B (ApoB) testing to popular “Ultimate Plan”

CAMBRIDGE, Mass., Jan. 3, 2023 /PRNewswire/ — InsideTracker, the leading personal health analysis and data-driven wellness guide that helps people increase their healthspan and live healthier longer, announced today the company’s popular Ultimate Plan will now also measure Apolipoprotein B (ApoB)—an essential indicator of heart health. Read more...

Read More

[BeetleSat in Business Wire] NSLComm’s BeetleSat LEO satellite successfully launched via SpaceX Falcon 9 rocket

MIAMI–(BUSINESS WIRE)–BeetleSat (the Company), formerly known as NSLComm, a fast-growing satellite technology start-up, today announced the successful launch of its second nanosatellite from Cape Canaveral, Florida, onboard a SpaceX Falcon 9 rocket. Now in Sun-synchronous orbit (SSO) at 550Km altitude, the nanosatellite will provide BeetleSat’s public sector customer with store and forward, very high throughput satellite communication services. Today’s launch is another step forward in the Company’s strategy to become one of the world’s leading satellite service operators through the creation of a groundbreaking low-Earth orbit (LEO) constellation that will enable secure, low-latency, high-throughput, and cost-effective point-to-point communications from anywhere on earth. Read more...

Read More

Newsletter: Drug-free migraine relief + Better dental implants

Top investment opportunitiesStartup of the Week: Magdent, empowering successful dental implantsWanted: More investment in breakthrough climate techGrab a December Discount for Summit until Jan. 5Air EV completes successful test voyageTheranica: Drug-free migraine reliefInsightec receives FDA approval, patients enrolled for Mayo Clinic trialDubai’s NOW Money taps ThetaRay for financial crime preventionJapan’s largest cargo carrier joins Freightos platformCybersixgill: Cost of cyberattacks to reach $10.5T by 2025More than 4,000 high-tech jobs Startup of the WeekMagdent: Empowering successful dental implants Some 17M dental implant procedures are conducted every year, but the healing process is a slow one, leading many of them to fail. Magdent has created a proprietary pulsed electromagnetic device that significantly reduces the risk of implant failure. The Magdent-Miniaturized Electromagnetic Device (MED) is screwed on top of a dental implant and emits pulsed electromagnetic fields that stimulate bone formation and bone quality. It has been clinically proven to reduce the healing process from 6 months to 2 months, and increase bone-to-implant contact by 48%. The Magdent-MED device is CE approved and protected by 17 approved and pending patents, with an FDA...

Read More